Low Testosterone and Depression: What Does the Research Show?

The largest meta-analysis of randomized trials on this topic to date, published in JAMA Psychiatry in 2019, offers a more precise, if less dramatic, picture than some TRT-clinic marketing. Below, we explain what it actually found, what biological mechanisms underlie this link, and why the problem of overlapping symptoms is key to understanding why this topic is harder than it looks at first glance.

Several biologically plausible pathways could link testosterone to mood. Androgen receptors are present in numerous brain structures involved in emotional regulation, including the limbic system, and testosterone affects the activity of neurotransmitter systems tied to mood, including serotonergic and dopaminergic pathways. Testosterone also interacts with the hypothalamic-pituitary-adrenal (HPA) axis, responsible for the body's stress response, and some of its metabolites act as neurosteroids, directly affecting neuronal excitability independent of the classical nuclear androgen receptor action.

At the same time, testosterone affects factors that strongly influence psychological well-being in their own right, even without a direct effect on the brain: energy, libido, sleep quality, and muscle mass. A decline in these areas, typical of hypogonadism, can independently lower mood and well-being, creating a picture that, from the outside, looks like „depression caused by low testosterone,” but is in fact a complex consequence of many overlapping physiological changes, not a simple, direct hormonal effect on mood in the psychiatric sense.

This is the most important practical nuance in this topic: chronic fatigue, reduced libido, difficulty concentrating, and sleep disturbances are simultaneously classic symptoms of hypogonadism and common symptoms of depression. In a man presenting with these symptoms, it's hard to clearly separate which of the two possible causes — or both at once — is actually responsible, without appropriate workup covering both hormonal evaluation and psychiatric screening.

This problem also runs in the other direction and is a poorly understood confounding mechanism in observational studies: many factors, such as obesity, chronic stress, insomnia, sleep apnea, or chronic illness, independently lower both testosterone and mood, not through a direct causal relationship between these two variables, but through a shared third cause. This means some of the correlation between low testosterone and depression observed in cross-sectional studies may reflect not a direct hormonal effect on mood, but the independent action of a third factor on both variables simultaneously.

Despite the statistically significant meta-analysis result, it's worth emphasizing the scale of the effect in a practical clinical context: most of the studies included in Walther et al.'s analysis weren't originally designed with depression as the primary, headline endpoint, and recruited men for various reasons — low testosterone, hypogonadism, sometimes coexisting depressive symptoms of varying severity. This is meaningfully different from a trial dedicated specifically to treating diagnosed clinical depression using testosterone as a first-line intervention, where standard treatments — psychotherapy and antidepressants with documented effectiveness — have a much longer and more solid evidence history.

The meta-analysis's authors also explicitly flag a safety limitation: a lack of sufficiently large, long-term studies assessing the risk of adverse events associated with using testosterone specifically to treat depressive symptoms. That's an important caveat for anyone considering TRT primarily, rather than only additionally, with mood improvement in mind, without a confirmed, independent hormonal indication.

It's also important to distinguish this topic from the separate question of mood swings tied to testosterone injection pharmacokinetics (the gap between peak and trough concentration within a dosing cycle) — that's a different mechanism, concerning the dosing rhythm in men already on TRT, not the question of whether low testosterone itself is a cause of depression. We cover that separately in our article on TRT and mood.

Few medical topics are as prone to oversimplification as the link between testosterone and mood — in both directions, whether by dismissing it as meaningless or by treating TRT as a universal fix for low mood. The strongest available evidence, a meta-analysis of 27 randomized trials, shows something in between: a real, statistically significant, but moderate effect, independent of baseline testosterone level, requiring appropriate, independent workup both hormonally and psychiatrically, rather than assuming one blood test explains everything.